dealase

Biotech · Private company · Boston, MA, US

Quantum Simulation Technologies, Inc.

Track this companyFree. Adds Quantum Simulation Technologies, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials

NIH awards4

  • Binding free energy predictions for peptide drugs: A novel machine learning-based peptide simulation model for high-throughput computational lead optimization with quantum mechanical accuracy.Fiscal year 2026 · $1MNIH RePORTER 2R44GM152994-02 · fetched Nov 12, 2026
  • Next generation free energy perturbation (FEP) calculations--enabled by a novel integration of quantum mechanics (QM) with molecular dynamics allowing a large QM region and no sampling compromisesFiscal year 2025 · $994.1KNIH RePORTER 5R44GM150314-03 · fetched Nov 12, 2026
  • Binding free energy predictions for peptide drugs: A novel machine learning-based peptide simulation model for high-throughput computational lead optimization with quantum mechanical accuracy.Fiscal year 2024 · $272.4KNIH RePORTER 1R43GM152994-01 · fetched Nov 12, 2026
  • Next generation free energy perturbation (FEP) calculations--enabled by a novel integration of quantum mechanics (QM) with molecular dynamics allowing a large QM region and no sampling compromisesFiscal year 2024 · $1MNIH RePORTER 2R44GM150314-02 · fetched Nov 12, 2026